CM
CLBT icon

Caption Management’s Cellebrite CLBT Stock Holding History

Caption Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48,000
Closed -$723K – 1621
2025
Q4 		$865K Buy
+48,000
New +$862K 0.01% 1109
2024
Q4 		– Sell
-53,300
Closed -$898K – 1499
2024
Q3 		$898K Buy
+53,300
New +$791K 0.01% 807
2022
Q1 		– Sell
-30,428
Closed -$243K – 1513
2021
Q4 		$243K Buy
30,428
+25,428
+509% +$240K ﹤0.01% 1391
2021
Q3 		$46K Buy
+5,000
New +$52.3K ﹤0.01% 1438

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Caption Management's CLBT Position: Q1 2026 in Review

Caption Management sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 48,000 shares — an estimated $723K sold.

Caption Management first reported a position in CLBT in Q3 2021 and held it in 4 quarters. The position peaked at $898K in Q3 2024. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Caption Management reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 48,000 Cellebrite shares in Q1 2026, an estimated $723K.
  • Caption Management first reported a position in Cellebrite in Q3 2021 and held it in 4 quarters.
  • Caption Management's Cellebrite position peaked at $898K in Q3 2024.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.